Fifth Third Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81B Buy
1,963,490
+1,497,423
+321% +$1.52B 3.3% 4
2025
Q4
$501M Buy
466,067
+2,485
+0.5% +$2.38M 1.59% 11
2025
Q3
$354M Buy
463,582
+1,004
+0.2% +$747K 1.13% 14
2025
Q2
$361M Buy
462,578
+11,409
+3% +$8.87M 1.25% 12
2025
Q1
$373M Buy
451,169
+5,507
+1% +$4.58M 1.42% 13
2024
Q4
$344M Sell
445,662
-7,176
-2% -$5.94M 1.25% 15
2024
Q3
$401M Buy
452,838
+7,616
+2% +$6.85M 1.45% 12
2024
Q2
$403M Buy
445,222
+31,654
+8% +$25.3M 1.54% 10
2024
Q1
$322M Buy
413,568
+21,352
+5% +$15.2M 1.26% 15
2023
Q4
$229M Buy
392,216
+25,492
+7% +$14.9M 0.97% 20
2023
Q3
$197M Buy
366,724
+286
+0.1% +$147K 0.91% 22
2023
Q2
$172M Buy
366,438
+126,074
+52% +$52.9M 0.76% 28
2023
Q1
$82.5M Buy
240,364
+22,944
+11% +$7.74M 0.38% 76
2022
Q4
$79.5M Buy
217,420
+15,226
+8% +$5.4M 0.38% 75
2022
Q3
$65.4M Buy
202,194
+3,668
+2% +$1.16M 0.34% 78
2022
Q2
$64.4M Buy
198,526
+20,204
+11% +$6.06M 0.31% 82
2022
Q1
$51.1M Buy
178,322
+13,003
+8% +$3.35M 0.21% 117
2021
Q4
$45.7M Buy
165,319
+14,950
+10% +$3.79M 0.18% 127
2021
Q3
$34.7M Sell
150,369
-87
-0.1% -$21.5K 0.15% 142
2021
Q2
$34.5M Sell
150,456
-177
-0.1% -$35.6K 0.15% 138
2021
Q1
$28.1M Sell
150,633
-126
-0.1% -$24.6K 0.13% 154
2020
Q4
$25.5M Sell
150,759
-15,734
-9% -$2.35M 0.13% 151
2020
Q3
$24.6M Buy
166,493
+15,063
+10% +$2.33M 0.14% 140
2020
Q2
$24.9M Buy
151,430
+29,208
+24% +$4.48M 0.15% 138
2020
Q1
$17M Buy
122,222
+11,650
+11% +$1.6M 0.12% 148
2019
Q4
$14.5M Sell
110,572
-497
-0.4% -$57.6K 0.08% 189
2019
Q3
$12.4M Sell
111,069
-704
-0.6% -$78.4K 0.07% 201
2019
Q2
$12.4M Buy
111,773
+5,520
+5% +$650K 0.08% 196
2019
Q1
$13.8M Sell
106,253
-9,052
-8% -$1.1M 0.09% 184
2018
Q4
$13.3M Sell
115,305
-6,597
-5% -$737K 0.1% 173
2018
Q3
$13.1M Buy
121,902
+13,985
+13% +$1.4M 0.08% 190
2018
Q2
$9.21M Buy
107,917
+4,848
+5% +$398K 0.06% 229
2018
Q1
$7.97M Sell
103,069
-3,878
-4% -$312K 0.05% 246
2017
Q4
$9.03M Sell
106,947
-2,848
-3% -$242K 0.06% 228
2017
Q3
$9.39M Sell
109,795
-1,293
-1% -$106K 0.07% 220
2017
Q2
$9.14M Sell
111,088
-1,974
-2% -$161K 0.07% 217
2017
Q1
$9.51M Sell
113,062
-3,838
-3% -$307K 0.07% 208
2016
Q4
$8.6M Sell
116,900
-28,316
-19% -$2.11M 0.07% 226
2016
Q3
$11.7M Sell
145,216
-4,087
-3% -$327K 0.1% 186
2016
Q2
$11.8M Sell
149,303
-5,998
-4% -$452K 0.1% 185
2016
Q1
$11.2M Buy
155,301
+8,950
+6% +$677K 0.1% 195
2015
Q4
$12.3M Sell
146,351
-1,408
-1% -$117K 0.11% 194
2015
Q3
$12.4M Buy
147,759
+1,039
+0.7% +$87.7K 0.11% 185
2015
Q2
$12.3M Sell
146,720
-15,998
-10% -$1.22M 0.11% 187
2015
Q1
$11.8M Buy
162,718
+910
+0.6% +$64.8K 0.1% 187
2014
Q4
$11.2M Sell
161,808
-3,092
-2% -$209K 0.1% 192
2014
Q3
$10.7M Buy
164,900
+68
+0% +$4.3K 0.1% 190
2014
Q2
$10.2M Sell
164,832
-7,311
-4% -$436K 0.09% 192
2014
Q1
$10.1M Sell
172,143
-8,887
-5% -$496K 0.1% 184
2013
Q4
$9.23M Sell
181,030
-5,198
-3% -$260K 0.09% 190
2013
Q3
$9.37M Sell
186,228
-12,788
-6% -$669K 0.1% 188
2013
Q2
$9.78M Buy
+199,016
New +$10.8M 0.1% 170

Other funds holding LLY

Fifth Third Bancorp's LLY Position: Q1 2026 in Review

Fifth Third Bancorp increased its Eli Lilly (LLY) stake by 321% in Q1 2026, buying an estimated $1.52B and bringing the position to 1,963,490 shares worth $1.81B. The position accounts for 3.3% of the portfolio, ranked #4.

Fifth Third Bancorp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fifth Third Bancorp held 1,963,490 shares of Eli Lilly worth $1.81B as of Q1 2026.
  • Fifth Third Bancorp bought 1,497,423 Eli Lilly shares in Q1 2026, an estimated $1.52B.
  • Eli Lilly made up 3.3% of Fifth Third Bancorp's portfolio in Q1 2026, its #4 holding.
  • Fifth Third Bancorp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.